Prospective cohort study of corticosteroids for inflammatory bowel disease

Prospective cohort study of corticosteroids for inflammatory bowel disease - Prospective cohort study of corticosteroids for inflammatory bowel disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025778

Enrollment

600

Registered

2017-01-22

Start date

2017-01-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)patients of ulcerative colitis or Crohn disease 2)Partial Mayo score above2 or CDAI above149 3)with agreement

Exclusion criteria

Exclusion criteria: 1)colitis other than ulcerative colitis or Crohn disease 2)patients who have symptomatic gastrointestinal stenosis 3)patients who destine to undergo colectomy 4)serious infectious disease 5)patients who investigators and subinvestigators consider to be inappropriate to participate in this study

Design outcomes

Primary

Measure	Time frame
Response rates of 8 weeks after corticosteroids	—

Secondary

Measure	Time frame
Response rates at 30 weeks and 54 weeks after corticosteroids Remission rates at 8, 30 weeks and 54 weeks after corticosteroids The incidence of adverse events	—

Countries

Japan

Contacts

Public ContactMakoto Mutaguchi

Keio University Gastroenterology and Hepatology

m.mutaguchi@keio.jp03-3353-1211

Outcome results